The influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn’s disease patients in relation to mucosal healing
Author(s) -
Piotr Eder,
Liliana ŁykowskaSzuber,
Katarzyna Iwanik,
Iwona KrelaKaźmierczak,
Kamila StawczykEder,
Przemysław Majewski,
Krzysztof Linke,
Elaine W. Kay,
Aldona Woźniak
Publication year - 2015
Publication title -
folia histochemica et cytobiologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.384
H-Index - 40
eISSN - 1897-5631
pISSN - 0239-8508
DOI - 10.5603/fhc.a2016.0008
Subject(s) - cd31 , angiogenesis , lamina propria , medicine , immunohistochemistry , pathogenesis , vascular endothelial growth factor , tumor necrosis factor alpha , crohn's disease , pathology , argon plasma coagulation , intestinal mucosa , gastroenterology , disease , vegf receptors , endoscopy , epithelium
Immune-mediated angiogenesis may play an important role in the pathogenesis of inflammatory lesions in Crohn's disease (CD). The study aimed to assess the influence of anti-tumour necrosis factor (anti-TNF) therapy on the angiogenesis in relation to microscopic and endoscopic healing in CD patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom